COVID-19 Clinical Trials Available

The following clinical trials are available at Kettering Health Network as of May 1.

Convalescent Plasma – Mayo Clinic Trial

Eligibility Criteria:

  1. Age at least 18 years
  2. Lab confirmed diagnosis of COVID-19
  3. Hospitalized
  4. Severe disease or high risk of progression

Remdesivir Expanded Access – Gilead Pharmaceuticals (Only at Kettering Medical Center at this time)

Eligibility Criteria:

  1. Age at least 12 years old and weighing at least 40kg
  2. Hospitalized with confirmed Covid-19
  3. Requiring mechanical ventilation
  4. ALT < 5x upper limit of normal
  5. Absence of renal or hepatic failure

Ruxolitinib (IL-6 Inhibitor) Expanded Access – Parexel

Eligibility Criteria:

  1. 12 years of age or greater
  2. Diagnosis of Covid-19
  3. Severe disease – Respiratory rate>24, SpO2 <90% on RA, mechanical ventilation, ARDS, or multiorgan failure
  4. ALT < 4x upper limit of normal
  5. PLT >50k

For questions or to enroll a patient, please contact Jeffery Weinstein, MD, at (937) 371-5871 or Jeffrey.Weinstein@ketteringhealth.org or Allison Dymacek at Allison.Dymacek@ketteringhealth.org .

May 1, 2020

k-news is the internal news source for Kettering Health Network.

Visit us to see network updates, campus news, employee features, events, benefit updates, and more.